151 related articles for article (PubMed ID: 15618286)
1. Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor.
Miller SL; DeMaria JE; Freier DO; Riegel AM; Clevenger CV
Mol Endocrinol; 2005 Apr; 19(4):939-49. PubMed ID: 15618286
[TBL] [Abstract][Full Text] [Related]
2. Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells.
Miller SL; Antico G; Raghunath PN; Tomaszewski JE; Clevenger CV
Oncogene; 2007 Jul; 26(32):4668-78. PubMed ID: 17297458
[TBL] [Abstract][Full Text] [Related]
3. Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.
Harrington KM; Clevenger CV
J Biol Chem; 2016 Oct; 291(41):21388-21406. PubMed ID: 27489110
[TBL] [Abstract][Full Text] [Related]
4. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma.
McHale K; Tomaszewski JE; Puthiyaveettil R; Livolsi VA; Clevenger CV
Mod Pathol; 2008 May; 21(5):565-71. PubMed ID: 18246042
[TBL] [Abstract][Full Text] [Related]
6. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
Liu BP; Burridge K
Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
[TBL] [Abstract][Full Text] [Related]
7. EHD2 mediates trafficking from the plasma membrane by modulating Rac1 activity.
Benjamin S; Weidberg H; Rapaport D; Pekar O; Nudelman M; Segal D; Hirschberg K; Katzav S; Ehrlich M; Horowitz M
Biochem J; 2011 Nov; 439(3):433-42. PubMed ID: 21756249
[TBL] [Abstract][Full Text] [Related]
8. Vav family proteins couple to diverse cell surface receptors.
Moores SL; Selfors LM; Fredericks J; Breit T; Fujikawa K; Alt FW; Brugge JS; Swat W
Mol Cell Biol; 2000 Sep; 20(17):6364-73. PubMed ID: 10938113
[TBL] [Abstract][Full Text] [Related]
9. A novel and functional interaction between cyclophilin A and prolactin receptor.
Syed F; Rycyzyn MA; Westgate L; Clevenger CV
Endocrine; 2003; 20(1-2):83-90. PubMed ID: 12668872
[TBL] [Abstract][Full Text] [Related]
10. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
Heo J; Thapar R; Campbell SL
Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
[TBL] [Abstract][Full Text] [Related]
11. Vav2 is an activator of Cdc42, Rac1, and RhoA.
Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
[TBL] [Abstract][Full Text] [Related]
12. Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site.
Kline JB; Moore DJ; Clevenger CV
Mol Endocrinol; 2001 May; 15(5):832-41. PubMed ID: 11328862
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth.
Bourguignon LY; Zhu H; Zhou B; Diedrich F; Singleton PA; Hung MC
J Biol Chem; 2001 Dec; 276(52):48679-92. PubMed ID: 11606575
[TBL] [Abstract][Full Text] [Related]
14. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
15. Vav1, but not Vav2, contributes to platelet aggregation by CRP and thrombin, but neither is required for regulation of phospholipase C.
Pearce AC; Wilde JI; Doody GM; Best D; Inoue O; Vigorito E; Tybulewicz VL; Turner M; Watson SP
Blood; 2002 Nov; 100(10):3561-9. PubMed ID: 12411320
[TBL] [Abstract][Full Text] [Related]
16. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.
Hunter SG; Zhuang G; Brantley-Sieders D; Swat W; Cowan CW; Chen J
Mol Cell Biol; 2006 Jul; 26(13):4830-42. PubMed ID: 16782872
[TBL] [Abstract][Full Text] [Related]
17. The rho exchange factors vav2 and vav3 control a lung metastasis-specific transcriptional program in breast cancer cells.
Citterio C; Menacho-Márquez M; García-Escudero R; Larive RM; Barreiro O; Sánchez-Madrid F; Paramio JM; Bustelo XR
Sci Signal; 2012 Oct; 5(244):ra71. PubMed ID: 23033540
[TBL] [Abstract][Full Text] [Related]
18. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
19. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2.
Garrett TA; Van Buul JD; Burridge K
Exp Cell Res; 2007 Sep; 313(15):3285-97. PubMed ID: 17686471
[TBL] [Abstract][Full Text] [Related]
20. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND
Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
